Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Dendreon (DNDN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
1 new
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: DNDN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on DNDN
Mike Huckman
(225 followers)
Why Did Dendreon Execs Cash Out on Friday?
(Tue, May 5)
Biotech Analyst Eats Dendreon's Provenge Crow
(Thu, Apr 16)
Dendreon: Freaky Friday
(Fri, Apr 3)
More by Mike Huckman on DNDN »
SA Editor Miriam Metzinger
(531 followers)
Cramer's Mad Money - Hey Big Spenders (11/5/09)
(Fri, Nov 6)
Cramer's Lightning Round - Dendreon Is Real (7/7/09)
(Wed, Jul 8)
Cramer's Lightning Round - Mindshare Is Going Towards Bing (6/22/09)
(Tue, Jun 23)
More by SA Editor Miriam Metzinger on DNDN »
Mike Havrilla
(1924 followers)
BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte
(Fri, Sep 25)
Tracking Healthcare Trends and More
(Wed, Aug 5)
Access Pharma: A Smallcap Cancer Biotech Call Option Trade
(Thu, May 28)
More by Mike Havrilla on DNDN »
Most followed authors on DNDN
TraderMark
(3729 followers)
Best Performing Stocks of the Last Quarter
(Mon, Jun 15)
A Chance to Get Back in the Market
(Tue, Apr 28)
More by TraderMark on DNDN »
Bespoke Investment Group
(3504 followers)
Best Performing Stocks Since 3/9/09 and 10/9/07
(Thu, Nov 12)
The Top 25
(Thu, Oct 1)
Russell 3,000 Stocks Up More than 200% Year to Date
(Sun, Jun 28)
More by Bespoke Investment Group on DNDN »
SA Editor Rachael Granby
(2020 followers)
Wall Street Breakfast: Must-Know News
(Wed, Apr 29)
More by SA Editor Rachael Granby on DNDN »
Newest authors on DNDN
Matthew Goldstein
(75 followers)
SEC Shouldn't Rest on Flash Trading Ban
(Fri, Sep 18)
More by Matthew Goldstein on DNDN »
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on DNDN »
Beacon Asset Managers
(130 followers)
Dendreon: Charting the Course to Big Profits
(Wed, Jun 10)
More by Beacon Asset Managers on DNDN »
Most commented on DNDN
Michael Murphy
(527 followers)
A Biotech Triple Play: Dendreon, BioCryst and Arena
(Mon, May 25)
Is Dendreon a $360 Stock - Or Is That Too Low?
(Wed, Apr 22)
More by Michael Murphy on DNDN »
Mike Huckman
(225 followers)
Why Did Dendreon Execs Cash Out on Friday?
(Tue, May 5)
Biotech Analyst Eats Dendreon's Provenge Crow
(Thu, Apr 16)
Dendreon: Freaky Friday
(Fri, Apr 3)
More by Mike Huckman on DNDN »
Theodore Cohen
(2 followers)
Dendreon's Provenge: Government Agencies Play Hide and Seek With Facts
(Thu, Jun 12)
Dendreon: The Provenge Approval Scandal, One Year Later
(Wed, May 7)
Dendreon: The FDA's Commissioner Doth Protest Too Much!
(Mon, Apr 21)
More by Theodore Cohen on DNDN »